Answer
Ipilimumab (Yervoy), alone or combined with nivolumab, is indicated for adults and adolescents aged 12 years and older with advanced unresectable or metastatic melanoma.
Sources for this answer
- YERVOY 5 mg/ml concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 46Document updated
Sources checked